Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Noah Greco"'
Autor:
Kenneth Wha Eng, Ellen L. Verner, David Wilkes, Kentaro Ohara, Shaham Beg, John K. Simmons, Erika Hissong, Juan Miguel Mosquera, Aanavi Karandikar, Troy Kane, Bishoy Faltas, Kevin Holcomb, Manish A. Shah, Scott T. Tagawa, Eniko Papp, Nasser K. Altorki, Michael Sigouros, Ana M. Molina, Hussein Alnajar, Emily Patchell, Wael Al Zoughbi, Cora N. Sternberg, Murtaza Malbari, Rohan Bareja, Andrea Sboner, Samuel V. Angiuoli, Yariv Houvras, Laurel Keefer, Violeta Beleva Guthrie, Noah Greco, Donna Nichol, David M. Nanus, Daniel Bockelman, Gustavo C. Cerqueira, Olivier Elemento, Jesse Fox, Jyothi Manohar
Publikováno v:
The Oncologist
Background Characterization of circulating tumor DNA (ctDNA) has been integrated into clinical practice. Although labs have standardized validation procedures to develop single locus tests, the efficacy of on‐site plasma‐based next‐generation s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43ac33ab3c88a3cc1b1a498c68bcbb9c
https://doi.org/10.1002/onco.13905
https://doi.org/10.1002/onco.13905
Autor:
Hussein, Alnajar, Hiranmayi, Ravichandran, André, Figueiredo Rendeiro, Kentaro, Ohara, Wael, Al Zoughbi, Jyothi, Manohar, Noah, Greco, Michael, Sigouros, Jesse, Fox, Emily, Muth, Samuel, Angiuoli, Bishoy, Faltas, Michael, Shusterman, Cora N, Sternberg, Olivier, Elemento, Juan Miguel, Mosquera
Publikováno v:
Cold Spring Harbor molecular case studies. 8(3)
Sarcomatoid urothelial carcinoma (SUC) is a rare subtype of urothelial carcinoma (UC) that typically presents at an advanced stage compared to more common variants of UC. Locally advanced and metastatic UC have a poor long-term survival following pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::32504139e1f3b0d93c2672434e9ffeab
https://pubmed.ncbi.nlm.nih.gov/35483877
https://pubmed.ncbi.nlm.nih.gov/35483877
Autor:
Howard A. Fine, Alessandro Romanel, Juan Miguel Mosquera, Marc H. Schiffman, Tuo Zhang, David S. Rickman, Mark A. Rubin, Rohan Bareja, Andrea Sboner, Wei Song, Mirjam Blattner-Johnson, Samaneh Motanagh, Shaham Beg, Kenneth Eng, Bhavneet Bhinder, Scott T. Tagawa, Christopher E. Barbieri, Olivier Elemento, Eleni Andreopoulou, Jenny Xiang, Terra J. McNary, Ana M. Molina, Joanna Cyrta, Himisha Beltran, Verena Sailer, Hanna Rennert, Theresa Y. MacDonald, Douglas S. Scherr, Chantal Pauli, Bishoy Faltas, Loredana Puca, Jeffrey P. Greenfield, Alexandros Sigaras, Manish A. Shah, Myriam Kossai, David Wilkes, Linda T. Vahdat, Qiulu Pan, David M. Nanus, Rob Kim, Koen van Besien, Francesca Demichelis, Allyson J. Ocean, Jacqueline Fontunge, Noah Greco, Rema Rao, Evan Sticca, Brian D. Robinson, David J. Pisapia, Sheena Sahota, Kevin Holcomb
Publikováno v:
JCO precision oncology. 3
PURPOSE We developed a precision medicine program for patients with advanced cancer using integrative whole-exome sequencing and transcriptome analysis. PATIENTS AND METHODS Five hundred fifteen patients with locally advanced/metastatic solid tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79e3a22090e458dd56170942012aeb96
https://pubmed.ncbi.nlm.nih.gov/31592503
https://pubmed.ncbi.nlm.nih.gov/31592503
Autor:
Terra J. McNary, Kyung Park, David Wilkes, Zhengming Chen, Anne-Katrin Emde, Jacqueline Fontugne, Yuzhuo Wang, Robert Kim, Dimple Chakravarty, Bishoy Faltas, Alessandro Romanel, Jason R. Banfelder, Scott T. Tagawa, Himisha Beltran, Jessica Padilla, Juan Miguel Mosquera, David M. Nanus, Tuo Zhang, Adrian Y. Tan, Dayna M. Oschwald, Andrea Sboner, Myriam Kossai, Hanna Rennert, Erick Herrscher, Marc H. Schiffman, David S. Rickman, Theresa Y. MacDonald, Jenny Xiang, Noah Greco, Brian D. Robinson, Mark A. Rubin, Hui Xue, Kenneth Eng, Davide Prandi, Olivier Elemento, Alexandros Sigaras, Agata Smogorzewska, Martin E. Gleave, Fabien Campagne, Neel Madhukar, Colin Collins, Vladimir Vacic, Francesca Demichelis, Chantal Pauli
Publikováno v:
JAMA oncology. 1(4)
Importance Understanding molecular mechanisms of response and resistance to anticancer therapies requires prospective patient follow-up and clinical and functional validation of both common and low-frequency mutations. We describe a whole-exome seque
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfba1cf91dd7b16a3534e2966e255975
https://pubmed.ncbi.nlm.nih.gov/26181257
https://pubmed.ncbi.nlm.nih.gov/26181257
Autor:
Beltran, Himisha, Eng, Kenneth, Mosquera, Juan Miguel, Sigaras, Alexandros, Romanel, Alessandro, Rennert, Hanna, Kossai, Myriam, Pauli, Chantal, Faltas, Bishoy, Fontugne, Jacqueline, Kyung Park, Banfelder, Jason, Prandi, Davide, Madhukar, Neel, Tuo Zhang, Padilla, Jessica, Noah Greco, McNary, Terra J., Herrscher, Erick, Wilkes, David
Publikováno v:
JAMA Oncology; Jul2015, Vol. 1 Issue 4, p466-474, 9p